Here we present a protocol to induce post-stroke depression in rats by occluding the middle cerebral artery via the internal carotid artery. We use the Porsolt forced swim test and the sucrose preference test to confirm and evaluate induced depressive moods.
Post-stroke depression (PSD) is the most recurrent of all psychiatric complications resulting from an ischemic stroke. A greater majority (about 60%) of all ischemic stroke patients suffer from PSD, a disorder considered to be an ischemic stroke-related precursor for increased death and degradation in health. The pathophysiology of PSD is still obscure. To study the mechanism of development and occurrence of PSD further, and to find out a therapy, we attempted to develop a new protocol that requires occluding the middle cerebral artery (MCA) via the internal carotid artery (ICA) in rats. This protocol describes a model of PSD induced in rats through the middle cerebral artery occlusion (MCAO). Also used in the experiment are the Porsolt forced swim test and the sucrose preference test to confirm and evaluate the depressive mood of the rats under investigation. Rather than inserting the catheter through the external carotid artery (ECA), as stipulated for the original procedure, this MCAO technique has the monofilament passing directly through the ICA. This MCAO technique was developed a few years ago and leads to a reduction in mortality and variability. It is generally accepted that the criteria used are preferred in the selection of biological models. The data obtained with this protocol show that this model of MCAO could be a way of inducing PSD in rats and could potentially lead to the understanding of the pathophysiology and the future development of new drugs and other neuroprotective agents.
Stroke is fourth on the list of death-perpetrating diseases in the United States1,2,3, while it causes the majority of disabilities in adults in developed countries4; this makes stroke a leading contender among the world's most significant health issues. Normalcy in stroke-surviving patients is rare, with about 15%-40% of survival victims suffering permanent disability, 20% requiring institutional care 3 months after stroke onset5, and about a third of 6-month survivals needing others to help them live through each day6. Stroke reportedly also accounts for the rising national health expenditures7. Estimates from the American Heart Association has stroke-related costs in the United States at over $50 billion in 20108.
Not only does stroke cause individuals' long-term damages, but some survivors tend to suffer emotional and behavioral disorders, such as dementia, fatigue, anxiety, depression, delirium, and aggression9,10,11,12,13,14. The most recurrent psychological sequel after a stroke is post-stroke depression (PSD), diagnosed in about 40%-50% of survivals15,16,17. Stroke-induced depression results in increased morbidity and mortality18,19,20,21,22. The pathophysiology of PSD is not known completely, but it is apparently caused by multiple factors and is linked to disability, cognitive impairment, and lesion site23.
The rat model of focal brain ischemia, created by MCAO, is the most widespread animal model of stroke24,25,26,27. In demonstrating the induction of PSD in rats by occluding the MCA via the ICA, techniques that minimize mortality and variability in the MCAO model are employed28.
The primary objective of this protocol is to outline the steps for inducing PSD in rats by occluding the MCA via the ICA, a modified model of MCAO, which reduces mortality and the outcome of variability28. Specific aims include performing neurological and histological examinations (determining the neurological severity score [NSS], the volume of the infarction zone, and brain edema) to verify the efficacy of MCAO and using behavioral tests to examine the influence of this MCAO procedure on the development of emotional disorders, mainly PSD.
The Animal Care Committee of the Ben-Gurion University of the Negev, Israel approved all treatment and testing procedures used in this protocol.
1. Preparation of Rats for the Experimental Procedure
NOTE: Select adult male Sprague-Dawley rats weighing 300-350 g.
2. Preparation of Rats for Surgery
3. Surgery (the MCAO Technique)
NOTE: Perform surgery as described by Boyko et al.28 and use the instruments provided by McGarry et al.29 and Uluç et al.30.
4. Post-surgical Recovery
5. Neurological Severity Score31
NOTE: This procedure is performed by two observers who do not take part in the surgical proceedings; they test the neurological deficits and grade motor deficits on a cumulative score of 0-432. The evaluation of this score may be performed at different time intervals; in this investigation, it was performed 50 min, 24 h, 7, 15, and 30 days post-surgery. Find below the steps for evaluating the NSS. Although not a necessity in this situation, this score is required to ascertain stroke in rodents in order to administer treatment.
6. Determination of the Infarct Volume (Hhistologic Examination)
7. Measurement of Brain Edema38
NOTE: Brain edema was measured 24 h after the last MCAO. Euthanize animals with severe neurological deficit interfering with eating and/or drinking for at least three days, more than 20% weight loss, hemiplegia or seizures.
8. Behavioral Paradigms
Histological findings (Table 1) revealed a statistically significant infarct volume as a percentage of total brain (p < 0.0001) post-MCAO when compared to animals in the sham-control group. Also reported was a statistically significant brain edema when the evaluation from the experimental group (p < 0.0003) was put side by side with that of the sham-control group.
The NSS scores obtained, as represented in Table 2, show lower neurological performances in the experimental group (MCAO) compared to higher figures for the sham-control group following Mann-Whitney tests: p < 0.001 after 50 min, p < 0.05 after 24 h, and p < 0.05 after 7 days.
Findings from the sucrose preference evaluations revealed that MCAO rats also consumed a significantly less amount of sucrose (p < 0.0001, Figure 2A) and had a longer immobility duration (p < 0.0001, Figure 2B) compared to the sham-operated rats.
Figure 1: Graphic demonstration of the protocol timeline. The various tests run on rats at different times are shown on the scheme: MCAO = middle cerebral artery occlusion at the beginning of the experiment; NSS = neurological severity score, 50 min, 24 h, and 7 and 30 days post-MCAO; and behavioral tests (sucrose preference and Porsolt forced swim tests) from days 30 to 33 post-MCAO. This figure has been modified from Ifergane et al.45. Please click here to view a larger version of this figure.
Figure 2: Sucrose preference test performed from days 30 to 33 with post-MCAO (n = 16) and sham-control rats (n = 14). Percentage (%) of sucrose preference. MCAO rats consumed less sucrose (p < 0.0001) than the sham-control rats, with a significant difference in sucrose consumption between the two groups shown in the figure. MCAO = middle cerebral artery occlusion. All data represent the group mean ± SEM. This figure has been modified from Ifergane et al.45. Please click here to view a larger version of this figure.
Figure 3: Porsolt forced swim test performed from days 30 to 33 post-MCAO (n = 16) and post-sham procedure (n = 14). Immobility duration (in seconds). The immobility time in the forced swim test was significantly longer in the MCAO group than in the sham group (p < 0.0002). MCAO = middle cerebral artery occlusion. All data represent the group mean ± SEM. This figure has been modified from Ifergane et al.45. Please click here to view a larger version of this figure.
Histological Findings | Middle cerebral artery occlusion group | Sham-operated group |
Total brain (Infarct volume) | 8.8% ± 6.5 | 0.3% ± 0.1 |
Brain Edema | 10.2% ± 4.6 | 2.6% ± 1.2 |
All data represent group mean ± S.E.M |
Table 1: Histological findings for infarct volume and brain edema. MCAO = middle cerebral artery occlusion (n = 5); sham (n = 5).
Neurological Severity Score | Middle cerebral artery occlusion group | Sham-operated group |
50 min post-surgery | 2.75 ± 0.14 | 0.0 ± 0.0 |
24 h post-surgery | 3.2 ± 0.15 | 0.0 ± 0.0 |
7 days post-surgery | 0.91 ± 0.2 | 0.0 ± 0.0 |
All data represent group mean ± S.E.M |
Table 2: Neurological severity score (NSS) for MCAO and sham-operated rats. MCAO = middle cerebral artery occlusion (n = 16); sham (n = 14). This table is taken from Ifergane et al.45.
One of the ways in which the MCAO technique presented here could be deemed safer than the original MCAO model is illustrated by the fact that the ECA and its branches, including the occipital artery, the terminal lingual, and the maxillary artery, are not compromised when occluding the MCA via the ICA. The original MCAO model's offset of the ECA (and its branches), by distally dissecting and coagulating them46, causes impaired mastication, owing to a compromise to the vascular supply to masticating muscles47. The destruction of the muscle could eventually cause the release of additional computational fluid dynamics. Contrary to the original MCAO technique in which access to the MCA occurs through the ECA, the technique described here is modified for stroke, with no occurrence of blood flow interruption in the ECA and its tributaries.
The most important arguments for preferring the novel MCAO model to the original MCAO rest in its ability to reduce variability in brain edema, infarct volume, and weight changes, significantly, as well as decrease MCAO-related mortality. Mortality in MCAO procedures is an important factor48; a 20% mortality rate is deemed reasonable49,50. The mortality rates (20% for original MCAO, 12.5% for novel MCAO, and 0% for control) in the current investigation were all within range of the acceptable rate, but the novel MCAO technique fared better than the original MCAO.
Rats undergoing the novel MCAO procedure lost less weight right after surgery and gained more weight by the end of the investigation than rats subjected to the original MCAO technique28. More weight loss and less weight gain in rats subjected to the original MCAO could result from ligating the ECA during surgery, which causes distal hypoperfusion in the facial, lingual, and maxillary arteries, as well as ischemia-related damages to the muscles that support mastication. If mastication is impaired, oral intake lessens, which, when coupled with catabolism, could account for weight loss, and in the long run, for a poor neurological outcome, morbidity, and death43. Access to the MCA via the ICA does not require interfering with the ECA and its branches. Thus, no impairments are triggered during the novel MCAO procedure, and no weight, morbidity, or mortality problems are experienced by rats undergoing the procedure.
The tests used to assess underlying depressive factors, such as depressive behavior, anhedonia, immobility, and learning and memory impairment, are standard procedures applied in animal models of depression51,52. A behavioral test, like the Porsolt forced swim test, is commonly affected by unusual motor abilities following MCAO. Here, this test was applied from days 30 to 33 after the surgical procedure to ascertain that the induction of PSD in the modified MCAO rats did not overly affect their motor abilities. According to the results, rats from the experimental group showed a comparable total escape behavior to that of sham-control rats. MCAO rats had significantly more escape failures, a significantly raised duration of immobility, and a reduced preference for sucrose when compared with sham-operated animals. This would suggest that this MCAO technique is a capable alternative to the original MCAO method.
The difference between inclusion and exclusion of rats in the MCAO procedure for a broader experimental evaluation depends very much on the outcome of the operation. With the MCAO-related PSD-inducing model, some unwanted side-effects of MCAO could be curtailed, leaving room for the inclusion of smaller, and possibly fragile rats in the MCAO procedure. The animal model of MCAO presented here provides a scenario for lessening unintended outcomes after MCAO-induced PSD because it has the potential to reduce variability in weight changes, brain edema, and infarct volume, as well as MCAO-related deaths. This technique could potentially serve as a tool for assessing future PSD therapies and provide preclinical data on the efficacy of therapeutic substances, as well as monitor other factors modifying modalities on the clinical outcome of stroke and PSD.
The authors have nothing to disclose.
We thank Professor Olena Severynovska of the Department of Physiology, Faculty of Biology, Ecology, and Medicine, Oles Honchar Dnipro University, Dnipro, Ukraine for her support and helpful contributions to our discussions. The data obtained are part of R.K.’s PhD thesis.
Absorbent pad | – | – | – |
Black lusterless perspex box | – | – | (120 cm × 60 cm × 60 cm), divided into a 25% central zone and the surrounding border zone |
Bottles | Techniplast | ACBT0262SU | 150 ml bottles filled with 100 ml of water and 100 ml 1%(w/v) sucrose solution |
Electric Shock | Heat System Ultasonic Inc. | – | – |
Horizon-XL | Mennen Medical Ltd | ||
Imaging System | Kodak | – | For imaging and quantification |
Monofilament | – | – | – |
Paper towels | Pharmacy | – | Dry towels used for keeping rats dry after immersing them in water |
Pexiglass cylinder | – | – | a 100 cm tall and 40 cm in diameter cylinder used for carrying out the forced swim test |
Purina Chow | Purina | 5001 | Rodent laboratory chow given to rats, mice and hamster is a life-cycle nutrition that has been used in biomedical researc for over 5 decades. Provided to rats ad libitum in this experiment |
Rat Cages | Techniplast | 2000P | Conventional housing for rodents. Was used for housing rats throughout the experiment |
Scanner | Canon CanoScan | 4200F | – |
Video Camera | ETHO-VISION (Noldus) | – | Digital video camera for high definition recording of rat behavior under open field test |